[Economic prerequisites of active influenza prevention].
Influenza and other acute infections of the upper respiratory tract are characterized by a high morbidity and mortality. As a result, they entail not only human but also economic consequences. A typical treatment is nonspecific and conservative. It consists of treatment with nonsteroid antiinflammatory drugs, antitussive drugs, hydratation, etc. Influenza is very often associated with complications especially in high risk groups (children, the elderly, chronically-ill people). The cost of treatment increases because of raising costs of pharmacotherapy and the increased absence from work. Vaccination is a safe and morbidity-diminishing method.
Grześk
Grzegorz
G
Katedry i Zakładu Farmakologii i Terapii Akademii Medycznej w Bydgoszczy. ggrzesk@aci.amb.bydgoszcz.pl
Gałaj
Andrzej
A
Korbal
Piotr
P
Durmowicz
Anna
A
Szadujkis-Szadurski
Leszek
L
Borys
Danuta
D
Grześk
Elzbieta
E
D000367:Age Factors; D000368:Aged; D002648:Child; D003362:Cost-Benefit Analysis; D003365:Costs and Cost Analysis; D016527:Drug Costs; D017048:Health Care Costs; D006801:Humans; D007252:Influenza Vaccines / Q000627:therapeutic use*; D007251:Influenza, Human / Q000150:complications / Q000191:economics* / Q000453:epidemiology / Q000517:prevention & control*; D011044:Poland / Q000453:epidemiology; D011314:Preventive Health Services; D012141:Respiratory Tract Infections / Q000191:economics / Q000517:prevention & control; D012307:Risk Factors
D007252:Influenza Vaccines